Member Info for travel_light

Big shout to the whole team. Everyone is playing their part, giving Big Al the ability to deliver.

Whilst we maybe frustrated we should remember the timescale for this is stupidly compressed. That means real people working long hours, weekend and being focused. Big Al even said as much in a recent RNS.

So on behalf of this share holder and many other thanks for the effort. Champions all of you.

Its gonna be layered. Identify clusters and hot spots. Hit them, let everyone else get on with life etc. Skin means spit test not needed everyday for everyone(but still in millions), good because they will be maxed out and needed in cluster areas. Skin makes spit test more efficient and that makes pcr more efficient.

Good luck to all Skin teams working on this. You are appreciated ! Sometimes that’s not always clear here.

links already posted but maybe easier if near top of chain

https://www.bbc.co.uk/sounds/play/m000ls8h

forward to 2:17

thanks, worth a read. US focused, but the bit at the end about lab based antigen test was interesting.

Phew, I had a vision of you being the grim reaper for a second.

If people don’t read posts with 0 likes how will it get to one like ?

Anyway I’m looking forward to 7am RNS, which will likely cause a nice debate.

AS01 I think without testing there is 0 hope.

If cheap rapid accurate tests were avaialable combined with sensible measures then India being on the itinerary might be possible.

Tests provide visibility. If infection rate low and can be shown to be low why not. The way to get it low is to test, track and isolate.

Vaccines will help but without testing it is very hard to see if they have been effective.

Chengdo04 was offering a +ve, maybe funding out more about state of play would be helpful.

Hoping that big Al has a entertainment feel for news

Monday one was hmmmm

Tuesday was a ahah

Hopefully....
Wednesday ..... great

Thursday....awesome

Friday .... can’t say, lse will filter it.

Just a hope, not a fact, not a prediction, not an opinion :-D

yep, the recurring revenue bundle is the future, but elements must still be close to best of breed. As soon as something less than ideal put into bundle and the customer then says hang on I can get Best of Breed for that bit from company XYZ, the magic breaks. They might even find that component for next to free cos foot in door is worth a lot. Company XYZ has foot in door and starts to sell in their own Rundle. I suspect Skin will need to do that to establish bigger footprint. Give away covid detection if customer buys 3 other components, hammer the competition into oblivion and TAKE OVER THE WORLD.

feel i might be teaching my grandmother to suck eggs and being a dick, sorry. Just a awesome opportunity, difficult to sit on hands.

I too would like to see a webinar about how AI is being used.

https://www.theguardian.com/us-news/2020/aug/17/los-angeles-schools-covid-19-tests?CMP=Share_iOSApp_Other

reading further Avacta has several PD-L1 related items in pipe, so ava004 may well still be in house.
Several undisclosed.
Multiple shots at goal, always nice.
https://avacta.com/therapeutics/pipeline/

Money in, but LG doing all the work. Pure earning stream, I think we will be able to order sides at the AGM, I’m going to have beans AND a pickled onion.

RK companies with one drug, how much do TO generally cost. I know different drugs have different value but often big companies need a big buy to make all the work meaningful. What’s the sweet spot?

Affimers flexible, so there maybe more than one and they are using ava004 data to try others out.

Web still says AVA004 in avacta pipe. They also just took on a big wig for thus sort of thing. Talk about minimum info ;-)

In the release

LG Chem has the exclusive rights to develop and commercialise, on a world-wide basis, Avacta's Affimer PD-L1 inhibitor with Affimer XT serum half-life extension.

Avacta pipeline on web

Its lead Affimer® programme is a PD-L1 antagonist which will form the basis of future bispecifics and TMAC drug conjugates.

Does this mean Avacta has sold its first treatment using affimers to LG. Worth billions if it gets through trials.

Also more targets being looked at, no mention but would be cool if they included Covid.

Med USA might have something to say about Medusa19 using similar name. Trademarks are tricky.

If kNN method is used could it be called a Large Aligned Vector Set

Ok wanted to bump this for Monday.

I’ll get my coat.

Top

Please

Maybe next version, or the one after could detect infections of different type in the air. Boffins need companies to help them.

https://www.sciencedaily.com/releases/2020/04/200421112520.htm